Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Newly Diagnosed Lung Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 12 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00083161
What this trial is testing

Cisplatin, Etoposide, and Cyclophosphamide in Treating Patients With Extensive-Stage Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Gundersen Lutheran Health System 8
Testing effectiveness (Phase 2)Study completedNCT00043862
What this trial is testing

The Study Of An Oral Drug Called A Radiation Sensitizer In Patients With Newly Diagnosed Small Cell Lung Cancer (SCLC)

Who this might be right for
Lung Cancer, Small CellSmall Cell Lung Cancer
GlaxoSmithKline 60
Testing effectiveness (Phase 2)Study completedNCT00294762
What this trial is testing

Erlotinib (Tarceva) as a Single Agent or Intercalated With Combination Chemotherapy in Patients With EGFR Positive NSCLC

Who this might be right for
Carcinoma, Non-Small-Cell Lung
OSI Pharmaceuticals 143
Post-approval studies (Phase 4)UnknownNCT06357598
What this trial is testing

Preoperative Neoadjuvant Immunotherapy Combined With Chemotherapy for Stage Ⅲ Unresectable Non-small Cell Lung Cancer

Who this might be right for
Non-small-cell Lung Cancer (NSCLC)
The Affiliated Hospital of Qingdao University 30
Testing effectiveness (Phase 2)Study completedNCT00003657
What this trial is testing

High-dose ICE With Amifostine

Who this might be right for
Bladder CancerBrain and Central Nervous System TumorsCarcinoma of Unknown Primary+8 more
Dana-Farber Cancer Institute 24
Not applicableStudy completedNCT05872763
What this trial is testing

Participants in China With Non-Small-Cell Lung Cancer That is Unable to be Treated With Surgery

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Hoffmann-La Roche 901
Testing effectiveness (Phase 2)Study completedNCT00025610
What this trial is testing

Combination Chemotherapy in Treating Infants With Newly Diagnosed Neuroblastoma

Who this might be right for
Neuroblastoma
European Infant Neuroblastoma Study Group - 1999
Early research (Phase 1)Study completedNCT00004074
What this trial is testing

Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu

Who this might be right for
Advanced Adult Primary Liver CancerAnaplastic Thyroid CancerBone Metastases+124 more
National Cancer Institute (NCI) 15
Testing effectiveness (Phase 2)Study completedNCT00449020
What this trial is testing

Carboplatin, Irinotecan, and Radiation Therapy Followed By Docetaxel in Treating Patients With Newly Diagnosed Stage III Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
University of Miami 32
Not applicableStudy completedNCT01153399
What this trial is testing

A Non-interventional Study (NIS) Registry for the Epidemiological and Scientific Evaluation of Epidermal Growth Factor Receptor (EGFR) Mutation Status in Patients With Newly Diagnosed Locally Advanced or Metastatic Non Small Cell Lung Cancer (NSCLC) (Stage IIIB/IV Non-small Cell Lung Cancer).

Who this might be right for
Non Small Cell Lung Cancer
AstraZeneca 589
Testing effectiveness (Phase 2)Looking for participantsNCT07354074
What this trial is testing

Study to Determine the Efficacy and Safety of Asciminib in Pediatric Patients With Ph+ CML-CP

Who this might be right for
Chronic Myelogenous LeukemiaLeukemia, Myelogenous, Chronic, Philadelphia Chromosome Positive
Novartis Pharmaceuticals 50
Early research (Phase 1)Study completedNCT00020579
What this trial is testing

MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma

Who this might be right for
Cancer
National Institutes of Health Clinical Center (CC) 75